Brain : Normal Variations and Benign Findings in Fluorodeoxyglucose-PET/Computed Tomography Imaging - 28/03/14
, Lisa Mosconi, PhD b, Alberto Pupi, MD aRésumé |
Brain 18F-fluorodeoxyglucose (18F-FDG) PET allows the in vivo study of cerebral glucose metabolism, reflecting neuronal and synaptic activity. 18F-FDG-PET has been extensively used to detect metabolic alterations in several neurologic diseases compared with normal aging. However, healthy subjects have variants of 18F-FDG distribution, especially as associated with aging. This article focuses on 18F-FDG-PET findings in so-called normal brain aging, and in particular on metabolic differences occurring with aging and as a function of people’s gender. The effect of different substances, medications, and therapy procedures are discussed, as well as common artifacts.
Le texte complet de cet article est disponible en PDF.Keywords : 18F-FDG-PET, Normal brain, Normal variants, Aging brain, Medications effect, Artifacts
Plan
| This work was supported in part by National Institute of Health/National Institute on Aging 5R01AG035137 and Alzheimer's Association IIRG-09-132030 (L. Mosconi). |
Vol 9 - N° 2
P. 129-140 - avril 2014 Retour au numéro
Article précédent
- Standardization and Quantification in FDG-PET/CT Imaging for Staging and Restaging of Malignant Disease
- Cristina Gámez-Cenzano, Francisco Pino-Sorroche
- Head and Neck : Normal Variations and Benign Findings in FDG Positron Emission Tomography/Computed Tomography Imaging
- Liselotte Højgaard, Anne Kiil Berthelsen, Annika Loft
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?